91 related articles for article (PubMed ID: 21586700)
1. Metabolomic linkage reveals functional interaction between glucose-dependent insulinotropic polypeptide and ghrelin in humans.
Rudovich NN; Nikiforova VJ; Otto B; Pivovarova O; Gögebakan O; Erban A; Möhlig M; Weickert MO; Spranger J; Tschöp MH; Willmitzer L; Nauck M; Pfeiffer AF
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E608-17. PubMed ID: 21586700
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine.
Rudovich NN; Dick D; Moehlig M; Otto B; Spranger J; Rochlitz HJ; Ristow M; Tschoep M; Pfeiffer AF
Regul Pept; 2005 Apr; 127(1-3):95-9. PubMed ID: 15680475
[TBL] [Abstract][Full Text] [Related]
3. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
Jones IR; Owens DR; Luzio S; Hayes TM
Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
[TBL] [Abstract][Full Text] [Related]
5. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
[TBL] [Abstract][Full Text] [Related]
6. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed.
Little TJ; Doran S; Meyer JH; Smout AJ; O'Donovan DG; Wu KL; Jones KL; Wishart J; Rayner CK; Horowitz M; Feinle-Bisset C
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E647-55. PubMed ID: 16684852
[TBL] [Abstract][Full Text] [Related]
7. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
Edholm T; Degerblad M; Grybäck P; Hilsted L; Holst JJ; Jacobsson H; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2010 Nov; 22(11):1191-200, e315. PubMed ID: 20584260
[TBL] [Abstract][Full Text] [Related]
8. In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue.
Pivovarova O; Gögebakan O; Osterhoff MA; Nauck M; Pfeiffer AF; Rudovich N
Regul Pept; 2012 Nov; 179(1-3):29-32. PubMed ID: 22960196
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
10. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
11. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
12. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.
Irwin N; Francis JM; Flatt PR
Biol Chem; 2011 Oct; 392(10):909-18. PubMed ID: 21851286
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependent insulinotropic polypeptide lowers branched chain amino acids in hyperglycemic rats.
Spégel P; Lindqvist A; Sandberg M; Wierup N
Regul Pept; 2014 Feb; 189():11-6. PubMed ID: 24412429
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
Kerr BD; Irwin N; O'Harte FP; Bailey CJ; Flatt PR; Gault VA
Biochem Pharmacol; 2009 Oct; 78(8):1008-16. PubMed ID: 19523458
[TBL] [Abstract][Full Text] [Related]
15. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
16. Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes.
Daousi C; Wilding JP; Aditya S; Durham BH; Cleator J; Pinkney JH; Ranganath LR
Clin Endocrinol (Oxf); 2009 Aug; 71(2):195-201. PubMed ID: 19178509
[TBL] [Abstract][Full Text] [Related]
17. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
18. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
[TBL] [Abstract][Full Text] [Related]
19. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
20. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
